Bioemagno's Clinical Pharmacology Unit conducted a human safety study in which the results determined class 2 medical device Ion Gel ZCM-25 at high dosing as non-irritating by demonstrating safe tolerability on the skin of healthy research subjects after repeated administration for 14 days. Funding supported by the Mexican government.